Nonalcoholic fatty liver disease and cholesterol gallstones: Which comes first?

The Metabolic Syndrome Is Associated with Complicated Gallstone Disease

(2016) Naim Ata et al.   CANADIAN JOURNAL OF GASTROENTEROLOGY

Gallstones associated with nonalcoholic steatohepatitis (NASH) and metabolic syndrome

(2016) Oktay YENER et al.   Turkish Journal of Gastroenterology

Relationship of Non-alcoholic Fatty Liver Disease With Cholecystectomy in the US Population

(2013) Constance E Ruhl et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Gallstone Disease Is Associated with More Severe Liver Damage in Patients with Non-Alcoholic Fatty Liver Disease

(2012) Anna Ludovica Fracanzani et al.   PLoS One

Metabolic syndrome and gallstone disease

(2012) Li-Ying Chen   WORLD JOURNAL OF GASTROENTEROLOGY

Metabolic syndrome and insulin resistance in relation to biliary tract cancer and stone risks: a population-based study in Shanghai, China

(2011) F M Shebl et al.   BRITISH JOURNAL OF CANCER

Statins as potential treatment for cholesterol gallstones: an attempt to understand the underlying mechanism of actions

(2011) Mohamed H Ahmed et al.   EXPERT OPINION ON PHARMACOTHERAPY

Cholelithiasis and markers of nonalcoholic fatty liver disease in patients with metabolic risk factors

(2011) Tomas Koller et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Insulin Resistance as a Risk Factor for Gallbladder Stone Formation in Korean Postmenopausal Women

(2011) Sang Soo Kim et al.   KOREAN JOURNAL OF INTERNAL MEDICINE

Long-term Statin Use and the Risk of Gallstone Disease: A Population-based Case-Control Study

(2010) R. Erichsen et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Presence of Gallstones or Kidney Stones and Risk of Type 2 Diabetes

(2010) C. Weikert et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Nonalcoholic Fatty Liver Disease Increases Risk of Death Among Patients With Diabetes: A Community-Based Cohort Study

(2010) Leon A Adams et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Triglycerides and gallstone formation

(2010) A.H.M. Smelt   CLINICA CHIMICA ACTA

Potential therapeutic uses for ezetimibe beyond lowering LDL-c to decrease cardiovascular events

(2010) M. H. Ahmed et al.   DIABETES OBESITY & METABOLISM

Statin administration and risk of cholecystectomy: a population-based case-control study

(2010) Eugene Merzon et al.   Expert Opinion On Drug Safety

Gallstone Disease Is Associated With Increased Mortality in the United States

(2010) Constance E. Ruhl et al.   GASTROENTEROLOGY

Lith Genes and Genetic Analysis of Cholesterol Gallstone Formation

(2010) Helen H. Wang et al.   GASTROENTEROLOGY CLINICS OF NORTH AMERICA

Metabolic disturbances in non-alcoholic fatty liver disease

(2009) Christopher D. Byrne et al.   CLINICAL SCIENCE

Statin Use and Risk of Gallstone Disease Followed by Cholecystectomy

(2009) Michael Bodmer et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Current treatment of non-alcoholic fatty liver disease

(2008) Mohamed H. Ahmed et al.   DIABETES OBESITY & METABOLISM

Effect of Ezetimibe on the Prevention and Dissolution of Cholesterol Gallstones

(2008) Helen H. Wang et al.   GASTROENTEROLOGY

Insulin Resistance is Associated with Gallstones Even in Non-obese, Non-diabetic Korean Men

(2008) Yoosoo Chang et al.   JOURNAL OF KOREAN MEDICAL SCIENCE

Hepatic insulin resistance directly promotes formation of cholesterol gallstones

(2008) Sudha B Biddinger et al.   NATURE MEDICINE

Molecular pathophysiology and physical chemistry of cholesterol gallstones

(2007) Helen et al.   Frontiers in Bioscience-Landmark